Literature DB >> 3108370

Precursor phenotype of lymphokine-activated killer cells in the mouse.

R R Salup, B J Mathieson, R H Wiltrout.   

Abstract

Lymphokine-activated killer (LAK) activity has been proposed to functionally differ from natural killer (NK) activity largely on the basis of a broader target cell spectrum and different kinetics of response to interleukin 2 (IL 2). Similarly, it has been proposed that the precursor cells for LAK activity are phenotypically distinct from NK cells. In most precursor studies, phenotype comparisons have been made between fresh NK cells and LAK cells which have been generated by 3 to 5 days of culture in IL 2. In the present study, we utilized positive selection with monoclonal antibodies to characterize the surface phenotype of precursor cells which give rise to rIL 2-augmented NK activity within 24 hr and to classically generated LAK activity which appears after 3 to 5 days of culture in rIL 2. The results demonstrated that highly purified (93 to 95%) Lyt-2+ or L3T4+ T lymphocytes were unable to generate appreciable amounts of either augmented NK activity or LAK activity when cultured with rIL 2, whereas the highly purified (98%) Lyt-2-, L3T4-, asialo GM1+ lymphocyte subset gave rise to both augmented NK and LAK activities. These findings demonstrate that both augmented NK and LAK activities can arise from precursors expressing the same phenotype. Overall, the results suggest that NK cells in mouse spleen constitute a major precursor component for the generation of LAK activity from that organ.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108370

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Inhibition of pregnancy viability in mice following IL-2 administration.

Authors:  B U Tezabwala; P M Johnson; R C Rees
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

2.  Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.

Authors:  H Belfrage; P Bhiladvala; G Hedlund; M Dohlsten; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

3.  Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL.

Authors:  A Punturieri; F Velotti; M Piccoli; R B Herberman; L Frati; A Santoni
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors.

Authors:  M Sensi; L Grazioli; M Rodolfo; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis.

Authors:  J F Bukowski; H Yang; R M Welsh
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Role of proliferation in LAK cell development.

Authors:  F J Ramsdell; H Shau; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Antiviral effect of lymphokine-activated killer cells: chemotaxis and homing to sites of virus infection.

Authors:  R J Natuk; J F Bukowski; J O Brubaker; R M Welsh
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytes.

Authors:  Geoffrey O Gillard; Maytal Bivas-Benita; Avi-Hai Hovav; Lauren E Grandpre; Michael W Panas; Michael S Seaman; Barton F Haynes; Norman L Letvin
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

9.  Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

Authors:  W H Chambers; N L Vujanovic; A B DeLeo; M W Olszowy; R B Herberman; J C Hiserodt
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.

Authors:  N L Vujanovic; R B Herberman; A A Maghazachi; J C Hiserodt
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.